| Application no. and date | 12715421.9 (espacenet) (Federated) (European Patent Register), 20120402 | | Patent/reg. no. and date | DK/EP 2694056, 20191016 | | Publication date | 20140212 | | Priority no. and date | US 201161470668 P, 20110401 | | EP pub. no. and date |
EP 2694056 20140212 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1526288 | | Inventor | DAVIES, Barry, Robert, AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | TERAPEUTISK BEHANDLING | | Int. application no. | GB2012050736 | | Int. publication no. | WO2012131399 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
